To directly investigate whether BMAL1 promotes the growth and survival of ccRCC cells, we measured clonogenicity in three cell lines derived from ccRCC tumor biopsies (786O, RCC4, and A498) in which we used shRNA to deplete the expression of endogenous BMAL1. The gene discussed is BMAL1; the disease is nonpapillary renal cell carcinoma.